Dr. Albert Ndzengue, MD

Dr. Ndzengue practices at UMMC Greenwood in Greenwood, Mississippi, part of Mississippi Institutions of Higher Learning.

Dr. Ndzengue's NPI, 1851692420, was assigned on November 12, 2010. Dr. Ndzengue holds Tennessee license 52436.

Dr. Ndzengue's primary practice is UMMC Greenwood, at 1401 River Rd, Greenwood, MS 38930 in Leflore County. The practice phone is (662) 459-7000.

Dr. Ndzengue's primary practice is UMMC Greenwood in Greenwood, Mississippi, part of Mississippi Institutions of Higher Learning. Dr. Ndzengue is also affiliated with Regional Medical Center. The medical group on file is Greenwood Leflore Hospital. Dmand AI also links Dr. Ndzengue to 2 more hospitals, 10 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ndzengue practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ndzengue's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Ndzengue's licenses on file in 3 states: Tennessee, Mississippi and New York.

CMS data shows 158 Medicare services from Dr. Ndzengue across 5 procedure codes in 2024, for 135 Medicare patients. Medicare paid $12,946 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Ndzengue in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ndzengue's median patient age at 54, with 62% women.

In 2024, Dr. Ndzengue wrote 261 Medicare Part D claims for 130 patients. 95% of them were for generic drugs. CMS names the drug for 128 of them, across 7 drugs with 11 or more claims each, at $624 in total drug cost. In 2023, CMS named 242 claims across 11 drugs.

Dr. Ndzengue accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Ndzengue from 1 drug or device company from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $131.